Trademark: 88891709
Word
DETECTWISE
Status
Registered
Status Code
700
Status Date
Tuesday, May 3, 2022
Serial Number
88891709
Registration Number
6715043
Registration Date
Tuesday, May 3, 2022
Mark Type
4000
Filing Date
Tuesday, April 28, 2020
Published for Opposition
Tuesday, February 15, 2022

Trademark Owner History
Parsons Corporation - Original Registrant

Classifications
9 Telethermographic testing systems sold as a unit comprised of thermal imaging cameras, infrared cameras, and computer hardware and recorded computer software for purposes of collecting, analyzing, and displaying information to help identify and prevent the spread of infectious diseases; biometric testing systems comprised of biometric scanners; systems comprised of downloadable electronic health assessment application questionnaires that use artificial intelligence analytics, downloadable and recorded computer software and user interfaces for end-users being touchscreens for electrotechnical and electronic devices, downloadable and recorded computer software that automates reporting, and risk analytics, to measure, analyze and detect indicia of, and possible exposure to, infectious diseases and viruses onsite at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities
44 Medical testing to assist in the diagnosis or treatment of infectious diseases, namely biological on-site testing; medical testing for diagnostic and/or reporting purposes; on-site medical testing for diagnostic or treatment purposes relating to infectious diseases, providing on-site medical testing and medical consultation facilities for preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by on-site medical laboratories for infectious diseases; on-site medical testing, namely, temperature testing, blood pressure testing, pulse rate testing and other testing for purposes of identifying and preventing the spread of infectious diseases; providing medical testing facilities utilizing telethermographic testing systems, providing medical testing facilities utilizing biometric testing systems, and testing centers located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; onsite virus testing at a mass scale, being medical testing for diagnostic or treatment purposes; providing on-site virus and infectious disease medical testing facilities with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing walk-up and drive-through infectious disease medical testing facilities; providing modular medical testing facilities for infectious diseases for use on site at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities; providing in-person health screening services and turn-key health assessment services at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying potential exposure to and carriers of infectious diseases and viruses and to prevent the spread of infectious diseases; providing modular facilities for on-site testing for infectious diseases for medical diagnostic or treatment purposes; providing mobile modular testing facilities for use in performing on-site testing for medical diagnostic or treatment purposes to prevent the spread of infectious diseases; providing modular testing facilities for on-site virus and infectious disease testing for medical diagnostic or treatment purposes with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing modular testing facilities for walk-up and drive-through infectious disease testing for medical diagnostic or treatment purposes, evaluation and analysis; providing modular testing facilities for infectious diseases for medical diagnostic or treatment purposes for use on site at public facilities, commercial facilities, and private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities; Providing mobile modular medical laboratory facilities to provide in-person infectious disease screening services for diagnostic purposes, and providing mobile modular sanitary installations with thermal imaging for dispensing antiseptic and antiviral agents for self-decontamination and for issuing personal protective gear, all located on-site at public facilities, commercial facilities, private facilities, transportation facilities, airports, entertainment and sports facilities, work facilities, office buildings, restaurants and food outlets, retail facilities, shopping malls, manufacturing facilities, hospitals, and other government owned, commercial, retail and residential facilities for purposes of identifying and preventing the spread of infectious diseases
42 Providing medical testing service in the field of infectious disease research and infectious disease classification to help prevent the spread of infectious diseases
DETECT WISE

Trademark Events
May 19, 2022
Teas Change Of Correspondence Received
May 19, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 19, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 3, 2022
Registered-Principal Register
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 12, 2022
Approved For Pub - Principal Register
Jan 11, 2022
Teas/Email Correspondence Entered
Jan 10, 2022
Correspondence Received In Law Office
Jan 10, 2022
Teas Response To Office Action Received
Jan 8, 2022
Notification Of Non-Final Action E-Mailed
Jan 8, 2022
Non-Final Action E-Mailed
Jan 8, 2022
Non-Final Action Written
Nov 16, 2021
Teas/Email Correspondence Entered
Nov 15, 2021
Correspondence Received In Law Office
Nov 15, 2021
Teas Response To Office Action Received
Oct 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 25, 2021
Teas Change Of Correspondence Received
Oct 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 25, 2021
Teas Change Of Owner Address Received
Jun 9, 2021
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Jun 8, 2021
Notification Of Non-Final Action E-Mailed
Jun 8, 2021
Non-Final Action E-Mailed
Jun 8, 2021
Non-Final Action Written
Jun 8, 2021
Use Amendment Accepted
May 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 5, 2021
Teas Change Of Correspondence Received
May 5, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
May 5, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 5, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 5, 2021
Teas Change Of Owner Address Received
May 5, 2021
Teas/Email Correspondence Entered
May 5, 2021
Correspondence Received In Law Office
Apr 30, 2021
Assigned To Lie
Jan 15, 2021
Teas Response To Office Action Received
Jan 16, 2021
Amendment To Use Processing Complete
Jan 16, 2021
Use Amendment Filed
Jan 15, 2021
Teas Amendment Of Use Received
Sep 11, 2020
Teas Change Of Correspondence Received
Sep 11, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 11, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 11, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 17, 2020
Notification Of Non-Final Action E-Mailed
Jul 17, 2020
Non-Final Action E-Mailed
Jul 17, 2020
Non-Final Action Written
Jul 13, 2020
Assigned To Examiner
May 11, 2020
New Application Office Supplied Data Entered In Tram
May 1, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24